Company: PCRX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001396814-25-000102
Chunk: 38

Company: Pacira BioSciences, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 38
---
  Q2 2025 Form 10-Q  |  Page 6

PACIRA BIOSCIENCES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED JUNE 30, 2025 AND 2024

(In thousands)

(Unaudited)

 Number of Shares OutstandingAdditionalPaid-InCapitalAccumulatedDeficitAccumulatedOtherComprehensiveIncome  Common SharesTreasury SharesCommon StockTreasury StockTotalBalance at March 31, 202547,121 (837)$47 $(25,121)$1,023,808 $(201,544)$1,351 $798,541 Vested restricted stock units669 — 1 — — — — 1 Common stock withheld for employee withholding tax liabilities on vested restricted stock units(200)— — — (5,286)— — (5,286)Common stock issued under employee stockpurchase plan101 — — — 1,569 — — 1,569 Stock-based compensation— — — — 15,472 — — 15,472 Purchase of treasury stock, inclusive of excise tax and broker fees— (1,956)— (50,394)— — — (50,394)Other comprehensive income (Note 11)— — — — — — 2,711 2,711 Net loss— — — — — (4,847)— (4,847)Balance at June 30, 202547,691 (2,793)$48 $(75,515)$1,035,563 $(206,391)$4,062 $757,767  

Number of Shares OutstandingAdditionalPaid-InCapitalAccumulatedDeficitAccumulatedOtherComprehensiveIncomeCommon SharesTreasury SharesCommon StockTreasury StockTotalBalance at March 31, 202446,517 — $47 $— $989,780 $(97,817)$152 $892,162 Vested restricted stock units381 — — — — — — — Common stock withheld for employee withholding tax liabilities on vested restricted stock units— — — — (378)— — (378)Common stock issued under employee stockpurchase plan